Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (421)
    • Blood Glucose Meters (3)
    • Complications (100)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (54)
    • Drug-Induced Hypo/Hyperglycemia (93)
    • Monitoring (75)
    • Natural Medicines/Supplements (8)
    • Prevention (26)
    • Treatment (185)
  • Endocrinology (9)
  • Hyperglycemia (22)
  • Hypoglycemia (21)
  • Other (15)
  • Prediabetes (2)
  • Resources (125)
  • Thyroid Disorders (41)
346 - 360 of 421 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Cinnamon for Patients with Type 2 Diabetes August 2004
Other: Exenatide (Synthetic Exendin-4) July 2004
Guideline: ADA Position Statement on Dyslipidemia Management in Adults with Diabetes (2004) June 2004
Guideline: American College of Physicians Clinical Practice Guideline on Lipid Control in the Management of Type 2 Diabetes Mellitus (2004) June 2004
Commentary: Lipid Control in Diabetes: Review of Clinical Practice Guidelines June 2004
Other: Travel and the Patient with Diabetes May 2004
Other: 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada December 2003
Other: Rosiglitazone (Avandia) Interaction With Gemfibrozil (Lopid) October 2003
Other: Acarbose for the Prevention of Cardiovascular Disease and Hypertension in Pre-Diabetic Patients September 2003
Other: Latent Autoimmune Diabetes of the Adult (Diabetes Type 1.5) September 2003
Other: Statin Therapy for Patients with Diabetes July 2003
Other: Repaglinide (Prandin) Interaction with Gemfibrozil (Lopid) June 2003
Other: New Drug: Avandamet (Rosiglitazone maleate/Metformin hydrochloride) April 2003
Chart: Summary of 2003 American Diabetes Association Recommendations March 2003
Other: Nuts and Diabetes January 2003
  • « Prev
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved